Frontlight ResearchEarly access
Migraine trials in South Korea
1 of 2 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine
- Where
- Gangseo-gu, Hwaseong-si, Seoul
- Age
- 18 years to 45 years
- People
- 723 worldwide
- Run by
- Pfizer
See details and how to joinNCT06641466 · EU 2024-517121-10-00